|
Originally published In Press as doi:10.1074/jbc.M003683200 on July 18, 2000
J. Biol. Chem., Vol. 275, Issue 40, 31369-31378, October 6, 2000
Cloning and Characterization of a Saccharomyces
cerevisiae Alkaline Ceramidase with Specificity for
Dihydroceramide*
Cungui
Mao §,
Ruijuan
Xu §,
Alicja
Bielawska¶,
Zdzislaw M.
Szulc¶, and
Lina M.
Obeid ¶
From the Division of General Internal Medicine, Ralph
H. Johnson Veterans Affairs Hospital and the ¶ Departments of
Medicine and Biochemistry, Medical University of South Carolina,
Charleston, South Carolina 29425
Received for publication, May 1, 2000, and in revised form, July 12, 2000
 |
ABSTRACT |
In a previous study, we reported that the
Saccharomyces cerevisiae gene YPC1 encodes an
alkaline ceramidase with a dual activity, catalyzing both hydrolysis
and synthesis of yeast ceramide (Mao, C., Xu, R., Bielawska, A., and
Obeid, L. M. (2000) J. Biol. Chem. 275, 6876-6884). In this study, we have identified a YPC1
homologue in S. cerevisiae that also encodes an alkaline
ceramidase. We show that these two ceramidases have different substrate
specificity, such that YPC1p preferentially hydrolyzes phytoceramide,
whereas the new ceramidase YDC1p hydrolyzes dihydroceramide
preferentially and phytoceramide only slightly. Neither enzyme
hydrolyzes unsaturated mammalian-type ceramide. In contrast to YPC1p,
YDC1p had only minor in vitro reverse activity of
catalyzing dihydroceramide formation from a free fatty acid and
dihydrosphingosine and no activity with phytosphingosine.
Overexpression of YDC1p had no reverse activity in non-stressed yeast
cells, but like YPC1p suppressed the inhibition of growth by fumonisin
B1 albeit more modestly. Deletion of YDC1 and
YPC1 or both did not apparently affect growth, suggesting
neither gene is essential. However, the ydc1 deletion mutant but not the ypc1 deletion mutant was sensitive to
heat stress, indicating a role for dihydroceramide but not
phytoceramide in heat stress responses, and suggesting that the two
enzymes have distinct physiological functions.
 |
INTRODUCTION |
Ceramide is a central molecule in the pathway of sphingolipid
metabolism in mammalian cells (1, 2). It is converted through the
action of a desaturase (3) from dihydroceramide that is synthesized
de novo from dihydrosphingosine and a fatty acyl-CoA1 by (a
CoA-dependent) ceramide synthase. Ceramide can also be generated from sphingomyelin by sphingomyelinase or be glycosylated to
yield more complex glycosphingolipids. Ceramide is also broken down by
ceramidases to generate sphingosine and a fatty acid.
Metabolism of yeast ceramides appears to be similar to that of mammals
(4). Phytoceramide, an equivalent of the mammalian ceramide, serves as
a building block of yeast complex sphingolipids. It is synthesized
de novo from a fatty acyl-CoA and phytosphingosine by (a
CoA-dependent) ceramide synthase. Phytosphingosine is
generated from dihydrosphingosine through hydroxylation by the action
of dihydrosphingosine hydroxylase (5, 6). Dihydrosphingosine is also
acylated by a fatty acyl-CoA to generate dihydroceramide through the
action of ceramide synthase. Phytoceramide (or dihydroceramide) accepts
an inositol-phosphoryl group to yield inositol phosphorylceramide (IPC).
Ceramide, as the building block of complex sphingolipids in eukaryotic
cells, not only is structurally essential for cell growth but also is
important in modulating different cellular events including apoptosis,
growth arrest, and stress responses (see reviews Refs. 2 and 7-10).
Importantly, its breakdown product sphingosine and the subsequent
metabolite sphingosine-1-P are also signaling molecules (11). As a
signaling molecule or a donor of signaling molecules, ceramide must be
tightly regulated in order to carry out multiple functions in cells.
Indeed, levels of ceramide in cells change in response to different
physiological environments or to different stimuli including growth
factors, cytokines (12), heat (4, 13), and pro-apoptosis agents (14).
Changes in ceramide levels in cells involve different enzymes. Among
these enzymes ceramidases are critical in controlling levels of
ceramide in mammalian cells.
Several mammalian ceramidases have been purified, characterized
biochemically, and subsequently cloned (15-17). They are classified as
acid, neutral, and alkaline ceramidases according to their pH optimum.
The acid ceramidase is localized to the lysosomes, and it is believed
to be responsible mainly for housekeeping catabolism of membrane
ceramide. Other membrane-bound ceramidases, which are considered as
neutral- or alkaline-type enzymes, are believed to be in involved in
signaling processes. For example, it was shown that mammalian alkaline
ceramidase is activated by platelet-derived growth factor (12) and that
both alkaline and neutral ceramidases are activated by interleukin 1
at a low concentration through tyrosine phosphorylation (18).
We recently cloned an alkaline ceramidase YPC1p from
Saccharomyces cerevisiae (19). YPC1p preferentially
deacylated phytoceramide to yield a free fatty acid and
phytosphingosine. It also slightly deacylated dihydroceramide to
generate a free fatty acid and dihydrosphingosine, but it did not act
on unsaturated ceramide. Importantly, this alkaline ceramidase had a
reverse activity of catalyzing formation of phytoceramide from a free
fatty acid and phytosphingosine in vitro and in cells.
Formation of phytoceramide by the reverse activity of YPC1p appears to
be an important alternative pathway for the synthesis of phytoceramide
when the CoA-dependent ceramide synthase is inhibited in
S. cerevisiae. Identification of YPC1p suggests that
breakdown of ceramides is conserved between yeast and mammals.
Another alkaline ceramidase was recently cloned from
Pseudomonas and mycobacterium (20). This enzyme also had
reverse activity but had no sequence homology to the yeast enzyme
YPC1p, indicating they belong to different classes of ceramidases. In
fact there was no homologous yeast sequence to the
Pseudomonas ceramidase. Interestingly the
Pseudomonas alkaline ceramidase shared a similarity in
protein sequence and many biochemical properties with the mouse neutral
ceramidase, which was recently purified and cloned from mouse liver
(16, 21) and a human mitochondrial ceramidase cloned from human kidney
(22).
On the other hand, a search of protein data bases for homology to YPC1p
identified that another yeast putative protein encoded by the open
reading frame YPL087w has 53% identity to YPC1p. In this
report, we present evidence that this protein (YDC1p) is another
membrane-bound alkaline ceramidase, with specific activity toward
dihydroceramide. We demonstrate that this protein also has reverse
activity albeit significantly less than that of YPC1p. We also show
that the deletion mutant of YDC1, but not YPC1,
endows sensitivity to heat stress. These data suggest that the
breakdown of phytoceramide and dihydroceramide in S. cerevisiae is catalyzed by different enzymes that have different
physiologic functions.
 |
EXPERIMENTAL PROCEDURES |
Yeast and Bacterial Strains--
Yeast strains used in this
study are listed in Table I and cultured
and maintained as described (19). Epicurean coli XL-1 and
SURE strains were used for most gene manipulations. E. coli Top10 strain was used for expression of yeast proteins under control of
Pbad promoter in the pBAD/His vector as described (19).
Construction of Mutants Deficient in YDC1 or Both YDC1 and
YPC1--
A copy of the wild type YDC1 gene in the diploid
strain JK9-3d a/ was replaced by a disruption module consisting of
the Kluyveromyces lactis URA3 gene
(Research Genetics, Inc.) flanked by the 5' end (nucleotide 16-46) and
3' end (nucleotide 892-926) portions of the YDC1 coding
region. Briefly, the disruption module amplified by PCR was transformed
into diploid cells by a lithium acetate method. The diploid cells
containing the ydc1 disruption module (deletion allele) were
sporulated, and the resulting tetrads were dissected as described (19).
All 10 tetrads dissected gave 4 viable spores, indicating that the
YDC1 gene is not essential for viability of the yeast. The
haploid strain ( ydc1) harboring the
ydc1 deletion allele was selected by prototrophs for uracil, and deletion of YDC1 was verified by PCR using a
forward primer (5' CAAGAATTTAAGCAAAAGGATATATCATAGAACCTAGTG 3')
upstream of the YDC1 coding region and the reverse
primer (the K. lactis internal 3' primer (Research Genetics,
Inc.)) located in the middle of the URA3 gene. By using
these two primers, the PCR would yield a product if the disruption
module is correctly integrated into the chromosome and replaces the
YDC1 gene. Diploid strain harboring both ypc1 and
ydc1 deletion alleles was created by crossing the two
haploid strains ydc1 and
ypc1. Sporulation and tetrad dissection of the
diploid strain yielded 4 normal spores, indicating that double
deletions of both YPC1 and YDC1 are viable. The
haploid strain harboring deletion of both ydc1 and
ypc1 was selected by geneticin resistance followed by
prototrophs for uracil. Since the URA3 gene interferes with
heat stress study, the wild type URA3 gene which replaced
the wild type YDC1 allele in both
ydc1 and
ypc1 ydc1 strains was replaced by
a truncated URA3 mutant that lacks the BbrP1
(restriction enzyme) fragment. Replacement of the wild type
URA3 gene was counter-selected by 5-fluoroorotic acid and
was verified by PCR.
Plasmid Construction for Protein Expression in Yeast--
The
open reading frame of the gene YDC1 was amplified by PCR (1 cycle of 94 °C for 2 min; 30 cycles of 94 °C for 30 s,
58 °C for 30 s, and 72 °C for 1 min; 1 cycle of 72 °C for
10 min) using the precision plus Taq polymerase
(Stratagene, Inc.) and the primers 5'
CGGGGTACCATGCTGTTCAGCTGGCCTTATCCAG 3' (forward) and 5'
CGGGAATTCTTAGTTATTCTTTTTTGTTTCATCATCTACC 3' (reverse). These primers contain the restriction sites (underlined)
KpnI and EcoRI, respectively, for the cloning
purposes. The amplified product was digested by restriction enzymes
KpnI and EcoRI and cloned into the
KpnI and EcoRI sites of the vector pYES2 to yield the construct pYES2-YPC1, thus expressing YDC1p under control of the
promoter Gal1. To facilitate detecting and purifying YDC1p, the coding region of the gene YDC1 was tagged with the
sequence (underlined) encoding the FLAG epitope peptide by PCR using
the forward primer 5'
CGGGGTACCATGGACTACAAGGACGACGATGATAAGCTGTTCAGCTGGCCTTATCCAG 3' and the reverse primer 5' CGGGAATTCTTAGTTATTCTTTTTTGTTTCATCATCTACC 3' as described (19). The PCR product was digested with
KpnI and EcoRI and cloned into the vector pYES2
as described above. The resulting construct pYES2/YDC1-FLAG that
expresses the FLAG-tagged protein YDC1p under the control of the
promoter Gal1, the construct pYES2-YPC1, and the empty
vector pYES2 were introduced into the strain yor1 by the
lithium acetate method after correctness of these constructs was
ensured by sequencing. The strain containing pYES2, pYES2-YPC1, or
pYES2/YDC1-FLAG was grown and maintained in SC-ura medium with 2%
glucose. Expression of YDC1p or the tagged YDC1p (YDC1p-FLAG) was
induced in SC-ura medium with 2% galactose, and YDC1p-FLAG was
detected by Western analysis using a monoclonal antibody against FLAG
peptide as described. Microsomes were prepared from the cells
expressing YDC1p-FLAG as described (19). Proteins were solubilized from
the microsomes with 0.25% Triton X-100 in the lysis buffer (25 mM Tris-HCl, pH 7.4, containing 5 mM
CaCl2, 150 mM NaCl, and 20 µg/ml CLAP), and
YDC1p-FLAG was purified by an anti-FLAG affinity column (Sigma) as
recommended by the manufacturer.
Cellular Localization Using GFP Tagging--
The YPC1
and YDC1 coding sequences without the stop codon were
amplified from the yeast genomic DNA and cloned into the
GFPuv-containing vector pYES2-GFPuv in frame with the GFPuv coding
sequence. The constructs pYES2-YPC1-GFPuv and pYES2-YDC1-GFPuv that
express the YPC1-GFPuv and YDC1-GFPuv fusion proteins, respectively,
were introduced into the yeast strain JK9-3d. Expression of the
YPC1-GFPuv and YDC1-GFPuv fusion proteins was induced in the SC-ura
medium containing 2% galactose for 6-12 h and was detected by Western blot analysis using the anti-GFP antibody. The fluorescence of the
yeast cells was examined under a Zeiss fluorescent microscope and
recorded by a CCD camera.
Expression of YDC1p in E. coli--
The coding sequence of the
gene YDC1 was excised by restriction enzymes KpnI
and EcoRI from the plasmid pYES2-YDC1 and cloned into
KpnI and EcoRI sites of the vector pBAD/His B
(Invitrogen) that was digested by the same enzymes to create
pBAD/His-YDC1, thus expressing the polyhistidine (His) and Xpress
tagged YDC1p under control of the araBAD promoter
(PBAD). pBAD/His and pBAD/His-YDC1 were introduced
into the E. coli strain TOP10 by electroporation. The tagged
YDC1p was expressed and purified as described (23).
Preparation of Radiolabeled
Ceramides--
[3H]Ceramide and phytoceramide were
synthesized as follows:
N-[9,10-3H]D-erythro-C16-ceramide
and
N-[9,10-3H]D-ribo-C16-phytoceramide
were prepared by acylation of the respective sphingoid bases with
[9,10-3H]palmitoyl chloride generated in situ
from [9,10-3H]palmitic acid as described (24).
D-Erythrosphingosine was obtained in stereo- and
enantio-specific synthesis as described previously (25).
Phytosphingosine was from Sigma.
N-Hexanoyl-D-erythro-[4,5-3H]dihydrosphingosine
([3H]C6-dihydroceramide),
D-erythro-[4,5-3H]dihydrosphingosine, and
D-erythro-[4,5-3H]dihydrosphingosine-1-phosphate
were from American Radiolabeled Chemicals (ARC, Inc.).
Measurements of Ceramidase Activity and Its Reverse
Activity--
Ceramidase activity was measured using
[3H]ceramide (2.75 nmol), [3H]phytoceramide
(2.5 nmol), or [3H]C6-dihydroceramide (2 nmol) as a substrate as described (19). To measure ceramidase activity,
20 µl (approximately 150 µg of proteins) of microsomes or a
purified protein was added to substrates, and reactions were incubated
at 30 °C for 40-90 min. Reactions were stopped by adding 300 µl
of methanol:chloroform (2:1) and dried under a SpeedVac. Lipids were
resolved by TLC; the reaction product palmitic acid or
dihydrosphingosine was identified, scraped, and measured by a
scintillation counter. Both the protein concentration and the time of
incubation were within the linear range for the assay. One unit of
ceramidase was defined as the amount of the enzyme needed to release 1 pmol of palmitic acid or dihydrosphingosine per min.
The reverse activity of ceramidase was measured using
[3H]palmitic acid (0.3 nmol) and phytosphingosine (or
dihydrosphingosine) (5 nmol) as substrates as described (19).
Microsomes were added to the above substrates and incubated at 30 °C
for 2 h. Both protein concentration and time of incubation were
within the linear range for the assay. Phospholipid determination on
microsomes showed that different microsomal preparations with equal
amount of proteins contained equal amount of lipids. One unit of the
reverse activity was defined as the amount of the enzyme needed to form
1 pmol of phytoceramide (or dihydroceramide) per min.
Sphingolipid Labeling--
Cells (3 × 107 in 1 ml of medium) were labeled with [3H]palmitic acid or
[3H]C6-dihydroceramide (5-10 µCi) at
30 °C for different periods as described (19). Total lipids were
extracted, deacylated by monomethylamine (20% in ethanol), and
resolved by TLC using the solvent system II (chloroform, methanol, 4.2 N ammonium hydroxide, 9:7:2, v/v) as described (19). TLC
plates were sprayed with EN3HANCE and radiographed on
BioMax films (Eastman Kodak Co.). Radiolabeled sphingolipids were
identified according to authentic standards. To quantify an individual
lipid, the radioactive bands were scraped and counted by a
scintillation counter (Beckman Instruments).
Protein Analysis--
Proteins were separated by SDS-PAGE and
were detected by Coomassie staining or Western blotting analysis by
following standard procedures.
Heat Tolerance Study--
Exponentially growing cells of yeast
strains were incubated at 50 °C for 40 min. The heat-treated cells
and those set at room temperature were plated onto YPD plates and
incubated at 30 °C for 2-3 days. The plates were photographed and
colony-forming units (CFU) were determined. The post-heat stress
viability was defined as a percentage of post-heat stress CFU to those
prior to heat stress.
 |
RESULTS |
Identification of Another Yeast Ceramidase--
To find potential
homologues for the YPC1 gene, we searched the
Saccharomyces Genome Database. We identified a putative
protein, encoded by the open reading frame YPL087w, that had
52% identity to the yeast alkaline ceramidase YPC1p over the entire
protein sequence. This protein had 317 amino acids, with a predicted pI of 6.77. Several highly conserved regions were found between the two
proteins (Fig. 1A). Similar to
YPC1p, the homologue was a very hydrophobic protein and shared a
similar hydropathy profile with YPC1p (Fig. 1B). Both
proteins were predicted to have several transmembrane domains (Fig.
1C), suggesting that this homologue is also an integral
membrane protein. Both proteins had an ER retention sequence
(KKXX, X represents any amino acid residue) at
their carboxyl termini, suggesting that they may be localized to the
ER. Based on similarities of protein sequence and hydropathy profiles,
this protein was predicted to be another ceramidase.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 1.
Comparison of protein sequence and
hydrophobic profiles of YDC1p and its homologue YPC1p.
A, alignment of the protein sequences of YDC1p and YPC1p was
done by the software MacVector. The conserved regions between the two
proteins are shaded and boxed. Phosphorylation
sites of cAMP-dependent kinase ( or ), protein
kinase C ( ), and tyrosine kinase ( ) were predicted by the PROSITE
program. ER retention sequences (*) at carboxyl termini are predicted
by the PSORT II program. B, protein hydropathy
profile is plotted according to the Kyte/Doolittle method.
C, transmembrane domains are predicted by the Agros
method.
|
|
To investigate whether the homologous gene encodes for a ceramidase
activity, we cloned its coding sequence into the vector pYES2 under the
control of the Gal1 inducible promoter. Sequencing confirmed
that the coding region was identical to that reported in the yeast
genomic data base. The vector pYES2 and the new construct were
transformed into the yeast strain yor1, and
gene expression was induced by galactose. Microsomes were prepared and
assayed for ceramidase activity using different ceramides as
substrates. Interestingly overexpression of the homologous protein
caused a substantial increase in ceramidase activity toward
C6-dihydroceramide (Fig.
2A), but only a slight
increase in the activity toward phytoceramide (Fig. 2B), and
no activity toward unsaturated ceramide (Fig. 2C). In
contrast to the homologue, microsomes from cells overexpressing YPC1p
hydrolyzed phytoceramide preferentially over dihydroceramide (Fig. 2,
A and B). These data suggest that this homologue
also encodes for a ceramidase activity; however, it had different
substrate specificity. We thus renamed this gene YDC1 as
yeast dihydroceramidase.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 2.
YDC1p hydrolyzes dihydroceramide
preferentially and phytoceramide only slightly but does not hydrolyze
saturated ceramide. Microsomes prepared from cells overexpressing
YDC1p or YPC1p were assayed for ceramidase activity toward
dihydroceramide (A), phytoceramide (B), or
unsaturated ceramide (C) as described under "Experimental
Procedures." The upper panels show the TLC separation of
products from substrates, and the bottom panels show
ceramidase activity. Data are the mean of one experiment performed in
duplicate and are representative of at least three independent
experiments. C6-dh-cer,
C6-dihydroceramide.
|
|
Tagged and Purified YDC1 Encodes a Ceramidase Activity--
We
demonstrated above that YDC1p encodes a ceramidase activity mainly
hydrolyzing dihydroceramide. However, we have not ruled out the
possibility that YDC1p is a regulator of ceramidase activity. To verify
that YDC1p is itself a ceramidase, we went on to express the YDC1p in
E. coli. To facilitate detection and purification, we tagged
the YDC1p with a polyhistidine (His) tag. The His-tagged YDC1p was
expressed in E. coli as analyzed by Western blot (data not
shown). The His-tagged YDC1p did not have ceramidase activity, probably
due to a post-translational modification required for the activity that
E. coli lacks. Therefore, we elected to express the YDC1p in
yeast cells. To facilitate purifying the YDC1p, we tagged it with an
epitope tag FLAG. Expression of the tagged YDC1p was induced by
galactose after the expressing construct pYES2-YDC1-FLAG was introduced
into yeast cells. Microsomes were prepared from the cells expressing
YDC1-FLAG or containing the empty vector pYES2-FLAG. Proteins were
extracted from microsomes with 0.25% Triton X-100 and applied to an
anti-FLAG affinity column. After washing, the FLAG-tagged protein was
eluted by a buffer containing FLAG peptide (10 µg/ml). The eluates
were resolved by SDS-PAGE, and proteins were detected by Coomassie
staining (Fig. 3A) and Western
blot analysis (Fig. 3B) using the anti-FLAG antibody. A
protein band with an apparent molecular mass of 37 kDa and a cluster of protein bands with apparent molecular mass ranging from 75 to 200 kDa were revealed by Coomassie staining as well as by Western
blotting in the YDC1-FLAG eluate but not in the vector control eluate.
The eluates were assayed for ceramidase activity. Fig. 3C
shows that the purified FLAG-tagged YDC1p, but not the vector control
eluate, had ceramidase activity toward C6-dihydroceramide.
The high molecular weight protein cluster could be aggregated YDC1-FLAG
since it is a very hydrophobic protein. Alternatively, it could be
YDC1-FLAG associated complexes. However, since YDC1p is highly
homologous to the alkaline ceramidase YPC1p, and purified YDC1p had
ceramidase activity toward C6-dihydroceramide, it is most
likely that the YDC1 gene encodes a ceramidase and less
likely that it is a regulator of enzymatic activity.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
The purified YDC1p expressed in yeast has
ceramidase activity. Proteins were extracted from microsomes
prepared from the cells with an empty vector or containing the FLAG
tagged YDC1p and were purified using an anti-FLAG affinity column as
described under "Experimental Procedures." Eluates were resolved by
SDS-PAGE, and proteins were detected by Coomassie staining
(A) or by Western blotting using anti-FLAG antibody
(B). The eluates were also assayed for ceramidase activity
as described under "Experimental Procedures"(C).
C6-dh-cer, C6-dihydroceramide.
|
|
YDC1p Is Also an Alkaline Ceramidase--
In our previous study,
we demonstrated that YPC1p is an alkaline ceramidase, with an optimal
pH of 9.5 (19). To study whether YDC1p has the same or a different pH
optimum, we measured the ceramidase activity of microsomal preparations
from cells overexpressing YDC1p using C6-dihydroceramide as
a substrate at different pH. Fig. 4 shows
that YDC1p has very low activity at acidic pH, moderate activity at
neutral pH, and the highest activity at alkaline pH. These data suggest
that similar to YPC1p, YDCp also belongs to the alkaline ceramidase
family.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
YDC1p has the highest activity toward
dihydroceramide at pH 9.5-10. Microsomes prepared from cells
overexpressing YDC1p were assayed for the activity of hydrolyzing
dihydroceramide at different pH values. Sodium acetate buffer was used
for pH 4.5-6; Tris-HCl buffer was used for pH 7-8. Glycine HCl buffer
was used for pH 9-10.5. Data are the mean of one experiment performed
in duplicate and are representative of at least three independent
experiments.
|
|
YDC1p Functions as a Ceramidase in Cells--
In vitro
YDC1p showed ceramidase activity. We next wanted to know whether in
cells YDC1p has the same ceramidase activity. Ceramidase activity in
cells was evaluated using
[3H]C6-dihydroceramide labeled at the C-4 and
C-5 positions of the dihydrosphingosine moiety. Similar to YPC1p,
overexpression of YDC1p enhanced breakdown of
[3H]C6-dihydroceramide, thus leading to
accumulation of dihydrosphingosine (DHS), phytosphingosine (PHS),
DHS-1-P, PHS-1-P, and the glycerolipids phosphatidylethanolamine, phosphatidylcholine, and
phosphatidylinositol (Fig. 5), suggesting
that YDC1p has endogenous ceramidase activity in cells.

View larger version (85K):
[in this window]
[in a new window]
|
Fig. 5.
Overexpression of YDC1p or YPC1p causes an
increase in breakdown of C6-dihydroceramide, thus leading
to accumulation of free long chain bases and their phosphates.
Cells containing the vector (pYES2), expressing YPC1p (pYES2-YPC1), or
YDC1p (pYES2-YDC1) were labeled with
[3H]C6-dihydroceramide as described under
"Experimental Procedures." Total lipids were extracted and resolved
by TLC, and sphingolipids were identified according to authentic
standards. PE, phosphatidylethanolamine; PC,
phosphatidylcholine; PI, phosphatidylinositol.
|
|
YDC1p Has the Reverse Activity of Synthesizing Dihydroceramide from
a Fatty Acid and Dihydrosphingosine--
To investigate if the YDC1p
has this reverse activity similar to its homologue YPC1p, microsomes
prepared from cells containing the empty vector (pYES2) or
overexpressing YDC1p were assayed for the reverse activity. Microsomes
were incubated with [3H]palmitic acid and
phytosphingosine or palmitic acid and dihydrosphingosine at 30 °C
for 2 h. The product, phytoceramide or dihydroceramide, was
analyzed by TLC and quantitated by a scintillation counter. Fig.
6A shows that microsomes from
YDC1p-overexpressing cells had no increase in the reverse activity
compared with the vector control cells when phytosphingosine and
palmitic acid were used as substrates. In contrast, the
YPC1-overexpressing cells had 30-fold higher activity than vector
control cells. When dihydrosphingosine and palmitic acid were used as
substrates microsomes from YDC1 cells had 3-fold higher reverse
activity than those from vector control cells (Fig. 6B),
whereas YPC1 cells had 30 times higher activity than control cells.
These results suggest that in yeast cells, YPC1p has a major reverse
activity of ceramidase and can use both DHS and PHS as substrates,
whereas YDC1p has only a minor reverse activity and can only use DHS as
substrate.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
YDC1p has a reverse activity of synthesizing
dihydroceramide from palmitic acid and dihydrosphingosine.
Microsomes were prepared from YDC1p or YPC1p-overexpressing cells and
were assayed for the reverse activity of ceramidase using palmitic acid
and phytosphingosine (A) or dihydrosphingosine
(B) as substrates in the presence or absence of fumonisin B1 (Fum).
The top panel shows the TLC profile of lipids, and
the bottom panel shows the reverse activity. Data are the
mean of one experiment performed in duplicate and are representative of
at least three independent experiments.
|
|
Overexpression of YDC1p Rescues from Fumonisin B1
Inhibition--
Overexpression of YPC1p endowed resistance to
fumonisin B1 because of its reverse activity to synthesize ceramide. We
demonstrated above that YDC1p had the reverse activity in
vitro when dihydrosphingosine and fatty acid were used as
substrates. We wondered whether in the presence of fumonisin B1,
overexpression of YDC1p could have the reverse activity in cells. Cells
containing pYES2-YDC1, the vector, or pYES2-YPC1 (as a positive
control) were grown on SC-ura plates containing 450 µM
fumonisin B1. Fig. 7A shows
that YDC1p also endowed resistance to fumonisin B1 albeit somewhat less
than YPC1p. This result shows that YDC1p could have the reverse
activity of ceramidase in cells under stress conditions but was not as effective as YPC1p.

View larger version (107K):
[in this window]
[in a new window]
|
Fig. 7.
Overexpression of YPC1p rescues from growth
inhibition by both fumonisin B1 and phytosphingosine, whereas
overexpression of YDC1p rescued from fumonisin B1 only. Cell
cultures were serially diluted and spotted onto SC-ura plates with 2%
galactose, containing fumonisin B1 (A), phytosphingosine
(B), or neither fumonisin B1 nor phytosphingosine, incubated
at 30 °C for 3 days, and photographed by an imaging system (Alpha
Innotech Inc).
|
|
Fumonisin B1 induced cytotoxicity in yeast could be due to blockage of
synthesis of ceramides and complex sphingolipids, or due to
accumulation of long chain bases and their phosphates, or both. We have
previously shown that a large proportion of exogenous long chain bases
were phosphorylated by long chain base kinases to yield long chain base
phosphates that are toxic to yeast cells (26). YPC1p or YDC1p could
endow resistance to fumonisin B1 in part by using accumulated long
chain bases to synthesize the yeast ceramides and attenuate the
cytotoxicity of the long chain base phosphates. To test this, we
evaluated if overexpression of either ceramidase could endow resistance
to the long chain bases phytosphingosine and dihydrosphingosine by
diverting them to phytoceramide and dihydroceramide using the reverse
activity. The strains containing the vector pYES2, pYES2-YPC1, and
pYES2-YDC1 were spotted onto SC-ura plates containing 25 µM phytosphingosine and 2% galactose, and growth
inhibition of the different strains was examined by the serial cell
dilution method described above. Fig. 7B shows that the YPC1
strain is more resistant to phytosphingosine than the vector strain,
whereas the YDC1 strain is only slightly more resistant to
phytosphingosine, suggesting that the YPC1 strain, and to a much lesser
extent, the YDC1 strain using its reversal action of ceramidase,
converts phytosphingosine to phytoceramide in cells when
phytosphingosine is in excess. This result is consistent with the
in vitro study, such that YPC1p, but not YDC1p, can use phytosphingosine as substrate to synthesize yeast ceramide. On the
other hand, neither the vector strain nor the YPC1 or YDC1 strains were
sensitive to DHS (up to 70 µM). This is compatible with
our other data2 indicating
that PHS but not DHS mediates yeast growth arrest.
Deletion of Both YDC1 and YPC1 Eliminates All Basal Ceramidase
Activity toward Phytoceramide and Dihydroceramide--
To study the
physiologic functions of YPC1p and YDC1p, we made deletion mutants of
YPC1, YDC1, or both. First, we examined how deletion of
these two genes affects metabolism of sphingolipids. We labeled the
mutants and their parental strain with [3H]palmitic acid
and analyzed total sphingolipids by TLC. Fig. 8 shows that deletion of either
YPC1 or YDC1 caused an increase in IPC, MIPC, and
M(IP)2C and a decrease in DHS-1-P and PHS-1-P compatible
with their function as ceramidases. Deletion of both YPC1
and YDC1 had an additive effect on metabolism of
sphingolipids. We speculated that complex sphingolipids increase in the
deletion mutants because ceramidase activity in these mutants is
significantly decreased or totally abolished. Therefore, we measured
ceramidase activity of these mutant strains. Microsomes prepared from
these strains and assayed for ceramidase activity (Table
II) showed that deletion of
YPC1 eliminated most of the basal ceramidase activity for
phytoceramide but slightly reduced the activity for dihydroceramide. In
contrast, deletion of YDC1 eliminated most of the activity
toward dihydroceramide but only slightly reduced the activity toward
phytoceramide. However, deletion of both YPC1 and
YDC1 completely removed the activity toward both
phytoceramide and dihydroceramide. These data suggest that YPC1p and
YDC1p indeed have their respective substrate specificity in cells and
are the only enzymes responsible for catabolism of the yeast ceramides (dihydroceramide and phytoceramide).

View larger version (112K):
[in this window]
[in a new window]
|
Fig. 8.
Deletion of YPC1,
YDC1, or both affects metabolism of sphingolipids in
cells. Cells were labeled with palmitic acid, and total lipids
were extracted and resolved by TLC after base hydrolysis as described
under "Experimental Procedures." Sphingolipids were identified
according to authentic standards. JK9-3d, the wild type
strain.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Ceramidase activities in the wild type, ypc1, ydc1, and ypc1
ydc1 strains
Microsomes were prepared from each strain and were assayed for
ceramidase activity towards phytoceramide and dihydroceramide as
described under "Experimental Procedures." Data are the mean of one
experiment performed in duplicate and a representative of at least
three independent experiments.
|
|
Deletion of Both YDC1 and YPC1 Eliminates Most of the Reverse
Activity of Ceramidase--
We also measured reverse activity
of ceramidase in the deletion mutants. Table
III shows that deletion of
YPC1 eliminated most of the reverse activity when either
phytosphingosine or dihydrosphingosine was used as substrates. Deletion
of YDC1 showed no change in the activity when
phytosphingosine and palmitic acid were used as substrates but showed
slight reduction in the activity when dihydrosphingosine and palmitic
acid were used as substrates. Deletion of both YPC1 and
YDC1 knocked out most of the activity when either
phytosphingosine or dihydrosphingosine were used as substrates along
with palmitic acid. These results suggest that the reversal action of
ceramidase in yeast cells is mainly carried out by YPC1p and to a much
lesser extent by YDC1p.
View this table:
[in this window]
[in a new window]
|
Table III
Reverse activity of ceramidase in the wild type, ypc1, ydc1, and
ypc1 ydc1 strains
The same microsomes as prepared in Table II were assayed for reverse
activity of ceramidase using palmitic acid and dihyrosphingosine or
phytosphingosine as substrates as described under "Experimental
Procedures." Data are the mean of one experiment performed in
duplicate and a representative of at least three independent
experiments.
|
|
Both YPC1p and YDC1p Are Localized to ER--
Both YPC1p and YDC1p
have an ER retention sequence, suggesting they may be localized to the
ER. We examined their localization by tagging YPC1p and YDC1p with a
green fluorescent protein (GFPuv). Western blotting analysis using an
anti-GFP antibody was performed on extracts from cells expressing
GFPuv, GFPuv-YPC1p, or GFPuv-YDC1p fusion proteins as described under
"Experimental Procedures." Fig.
9A shows that free GFPuv was
detected only in the 100,000 × g supernatant,
whereas both GFPuv-YPC1p and GFPuv-YDC1p were detected only in the
100,000-g pellet, suggesting that both YPC1p and YDC1p are membrane
proteins as predicted, and their localization in cells was not affected
by GFPuv tagging. The fluorescent pattern of exponentially growing
cells expressing the GFPuv-YPC1p or YDC1p fusion was recorded by a CCD
camera. Fig. 9B shows that GFPuv-tagged YPC1p and YDC1p have
a typical ER pattern shared by another lipid enzyme DHS-1-P phosphatase
YSR2, suggesting they are indeed localized to the ER where most enzymes
of sphingolipid metabolism are localized.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 9.
Both YPC1p and YDC1p are localized
to ER. YDC1p and YPC1p were tagged with a fluorescent GFPuv as
described under "Experimental Procedures." Expression of the tagged
proteins was induced in SC-ura medium containing 2% galactose. Cells
were disrupted by glass bead collision, and whole cell lysate was
fractionated into cytosolic and membrane fractions after removal of
nuclei. Proteins from the two fractions were separated by SDS-PAGE,
GFPuv, and the GFPuv fused YPC1p and YDC1p were detected by Western
blot analysis using anti-GFP antibody (A). Fluorescence of
cells was examined under a fluorescent microscopy and recorded by a
digital camera (B).
|
|
Deletion of YDC1, but Not YPC1, Causes a Decrease in Tolerance to
Heat Stress--
Yeast cells deficient in YPC1p, YDC1p, or both are
viable and have normal growth rates in both rich medium and defined
medium under permissive temperatures, suggesting that neither YPC1p nor YDC1p is essential. The yeast ceramides and other sphingolipids have
been implicated in the response to heat stress, whereby their levels
are elevated in heat-stressed cells (13, 27). Increased ceramides were
suggested to come from the de novo pathway (27). We
previously showed that elevation of dihydroceramide or phytoceramide imparted on yeast cells a sensitivity to heat stress, whereas elevation
of dihydrosphingosine-1-P has been implicated in heat resistance (26).
Deletion of either YPC1 or YDC1 caused an
increase in synthesis of complex sphingolipids due to decreased
breakdown of ceramides. To study whether the pathway of breakdown of
ceramide is involved in the process of heat stress, we investigated
heat stress responses in the mutants deficient in YPC1p, YDC1p, or both. Cells were incubated at 50 °C for 40 min, and post-heat viability was determined by CFU on YPD plates. Fig.
10 shows that the post-heat stress
viability of both the ydc1 and
ypc1 ydc1 mutant strains was lower than that
of either the ypc1 mutant or the wild type strains. The
ypc1 strain that lacks the ability to break down
phytoceramide had the same response as the wild type JK9-3d to heat. On
the other hand, the ydc1 that lacks the ability to break
down dihydroceramide was highly sensitive to heat stress. The
ypc1 ydc1 strain, like
ydc1, was also more sensitive to heat stress.
These results suggest that accumulation of dihydroceramide but not
phytoceramide may be responsible for mediating sensitivity to heat
stress. Alternatively, loss of breakdown product in the
ydc1 strain (dihydrosphingosine), but not in the ypc1 strain (phytosphingosine), could be responsible for
mediating this heat sensitivity.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 10.
Deletion of YDC1 confers a
sensitivity to heat. Exponentially growing cells from different
strains were diluted to the same density (4 × 105)
using YPD medium, and one portion of cells was heat-treated at 50 °C
for 40 min, and the other portion was set at room temperature. The
heat-treated cells were plated onto YPD plates after being cooled to
room temperature and were incubated at 30 °C for 2 days. The
non-stressed cells were diluted 100 times and plated onto YPD plates.
CFUs were counted. The post-heat shock viability of the strains was
defined as the percentage of post-heat shock CFUs over prior heat shock
CFUs.
|
|
 |
DISCUSSION |
In this study, we identified and cloned a homologue to the
S. cerevisiae phytoceramidase (YPC1p). We demonstrate that
this homologue is also an alkaline ceramidase that hydrolyzes
dihydroceramide specifically, and we named it yeast
dihydroceramidase (YDC1p). YDC1p shows
reverse activity of ceramidase in vitro; however, unlike
YPC1p, YDC1p has a minor reverse activity and only with dihydrosphingosine as substrate. In cells, YDC1p acts as a ceramidase under normal culture conditions, but the ceramidase action can be
reversed in the presence of fumonisin B1. Both YPC1p and YDC1p have an
ER retention sequence at their carboxyl termini, and we verify their
localization to the ER by GFP tagging. We also demonstrate that
deletion of YDC1 but not YPC1 renders cells
sensitive to heat stress, suggesting that dihydroceramide (or
dihydrosphingosine), but not phytoceramide (phytosphingosine), in yeast
may have a distinct role in response to heat stress.
Several ceramidases have been cloned from mammalian cells. These
include an acid lysosomal ceramidase (15), a mouse liver neutral
ceramidase (16), and its homologue a human kidney mitochondrial ceramidase (17). These latter two enzymes are homologous to the
Pseudomonas alkaline ceramidase (20). We have also recently identified and cloned a human homologue of the yeast alkaline ceramidases. Comparison of protein sequence revealed that our yeast
ceramidases and their human homologue are completely distinct from the acid lysosomal ceramidase as well as the mouse neutral ceramidase and the human mitochondrial ceramidase, which in turn are
also distinct from the acid ceramidase. Therefore, based on protein
sequence, it is not yet possible to predict a substrate-binding site.
As far as substrate specificity, the yeast ceramidases prefer
yeast-saturated ceramides as their substrates, whereas all the other
neutral and alkaline ceramidases described to date prefer unsaturated
ceramide (21, 22). The bacterial ceramidase also uses mammalian type
unsaturated ceramide as substrate; therefore, the enzyme may have a
role in bacterial invasiveness. In fact such a role was raised in the
study of Ohnishi et al. (28) where the
Pseudomonas ceramidase was implicated in hydrolyzing skin ceramides in atopic dermatitis. Therefore, whether these different ceramidases have distinct physiologic roles needs to be further studied.
Protein motif prediction using the PROSITE program revealed that
both YPC1p and YDC1p have putative cAMP protein kinase
tk;1phosphorylation sites and protein kinase C phosphorylation sites,
and YDC1p has a tyrosine kinase phosphorylation site (Fig.
1A). It has been shown that activity of mammalian neutral
and alkaline ceramidases is regulated by protein phosphorylation.
Whether the yeast ceramidases are phosphorylated and the
phosphorylation modifies their enzymatic activity awaits further study.
It is believed that ceramides are synthesized in the ER. Localizations
of YPC1p and YDC1p to the ER suggest that YPC1p and YDC1p have
immediate access to the yeast ceramide as soon as it is formed. The
benefit of the rapid access of these enzymes to the ceramides could be
to regulate turnover of ceramides most efficiently because ceramide
levels are crucial for the well being of yeast cells. YDC1p and YPC1p
are the only ceramidases in yeast cells, so the ER should be an
important pool for generating dihydrosphingosine and phytosphingosine,
the products of these enzymes. We previously showed that
dihydrosphingosine-1-P phosphatases (YSR2 and YSR3) are also localized
to the ER. These data suggest that the ER is the center of both
synthesis and breakdown of yeast sphingolipids.
In mammalian cells, it is believed that sphingosine is derived from
deacylation of ceramide by ceramidase and not from de novo
biosynthesis. Its subsequent metabolite sphingosine-1-P is also one of
the breakdown products of ceramide. Sphingosine and sphingosine-1-P
have been implicated in opposite cellular actions, such that
sphingosine suppresses cell growth and sphingosine-1-P promotes cell
proliferation. In yeast, sphingosine has not been detected, and both
dihydrosphingosine and phytosphingosine are synthesized de
novo. In our previous (19) and current studies, we clearly
demonstrate that both dihydrosphingosine and phytosphingosine are also
the breakdown products of dihydroceramide and phytoceramide, respectively, and these breakdown products can be phosphorylated by
kinases to form long chain base phosphates. The long chain base
phosphates are decreased in cells lacking either YPC1p or YDC1p,
indicating that these long chain base phosphates are in part from
breakdown of sphingolipids.
Deletion of YPC1, YDC1, or both does not affect
growth under normal conditions, suggesting yeast ceramidases may not be
mediators of cell growth and proliferation. However, deletion of
YDC1, but not YPC1, sensitizes cells to heat
stress. YDC1p and YPC1p use dihydroceramide and phytoceramide,
respectively, as substrate in cells. These results suggest that
dihydroceramide but not phytoceramide is responsible for the modulation
of the heat stress response. In a previous study we demonstrated that
overexpression of dihydrosphingosine-1-P phosphatase (YSR2) also
sensitizes cells to heat stress (26). Deletion of YDC1 is
similar to overexpression of YSR2 in that both have the same effect on
metabolism of sphingolipids as follows: causing an increase in
dihydroceramide and a decrease in dihydrosphingosine-1-P. Thus, we
conclude that changes in dihydroceramide, dihydrosphingosine-1-P, or
both are responsible for the heat stress sensitivity.
 |
ACKNOWLEDGEMENT |
We thank Dr. Yusuf Hannun for critical review
of the manuscript and helpful discussions.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants AG16583 and AG12467.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF214455.
§
These authors contributed equally to this work.
To whom correspondence should be addressed: Division of
General Internal Medicine, 114 Doughty St., Rm. 604 STB, P. O. Box 250779, Charleston, SC 29425. Tel.: 843-876-5173; Fax: 843-876-5191; E-mail: obeidl@musc.edu.
Published, JBC Papers in Press, July 18, 2000, DOI 10.1074/jbc.M003683200
2
N. Chung, C. Mao, J. Heitman, Y. A. Hannun, and
L. M. Obeid, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
CoA, coenzyme A;
YDC1, the yeast dihydroceramidase gene;
YDC1p, the gene product of
YDC1;
YPC1, yeast
phyto-ceramidase gene;
YPC1p, the product of
the YPC1 gene;
PCR, DNA polymerase chain reaction;
DHS, dihydrosphingosine;
DHS-1-P, dihydrosphingosine 1-phosphate;
PHS, phytosphingosine;
PHS-1-P, phytosphingosine 1-phosphate;
IPC, inositol
phosphoceramide;
MIPC, mannosylated IPC;
ER, endoplasmic reticulum;
GFP, green fluorescent protein;
CFU, colony-forming units;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Luberto, C. H. Y.
(1999)
Lipids
34,
5-11
|
| 2.
|
Merrill, A. H., Jr.,
Schmelz, E. M.,
Dillehay, D. L.,
Spiegel, S.,
Shayman, J. A.,
Schroeder, J. J.,
Riley, R. T.,
Voss, K. A.,
and Wang, E.
(1997)
Toxicol. Appl. Pharmacol.
142,
208-225
|
| 3.
|
Michel, C.,
van Echten-Deckert, G.,
Rother, J.,
Sandhoff, K.,
Wang, E.,
and Merrill, A. H., Jr.
(1997)
J. Biol. Chem.
272,
22432-22437
|
| 4.
|
Dickson, R. C.,
and Lester, R. L.
(1999)
Biochim. Biophys. Acta
1438,
305-321
|
| 5.
|
Grilley, M. M.,
Stock, S. D.,
Dickson, R. C.,
Lester, R. L.,
and Takemoto, J. Y.
(1998)
J. Biol. Chem.
273,
11062-11068
|
| 6.
|
Haak, D.,
Gable, K.,
Beeler, T.,
and Dunn, T.
(1997)
J. Biol. Chem.
272,
29704-29710
|
| 7.
|
Hannun, Y. A.,
and Obeid, L. M.
(1997)
Biochem. Soc. Trans.
25,
1171-1175
|
| 8.
|
Hannun, Y. A.,
and Obeid, L. M.
(1997)
Adv. Exp. Med. Biol.
407,
145-149
|
| 9.
| Hannun, Y. A. (1997) Adv. Exp. Med. Biol. 305-312
|
| 10.
|
Hannun, Y. A.
(1996)
Science
274,
1855-1859
|
| 11.
|
Spiegel, S.,
Cuvillier, O.,
Edsall, L. C.,
Kohama, T.,
Menzeleev, R.,
Olah, Z.,
Olivera, A.,
Pirianov, G.,
Thomas, D. M.,
Tu, Z.,
Van Brocklyn, J. R.,
and Wang, F.
(1998)
Ann. N. Y. Acad. Sci.
845,
11-18
|
| 12.
|
Coroneos, E.,
Martinez, M.,
McKenna, S.,
and Kester, M.
(1995)
J. Biol. Chem.
270,
23305-23309
|
| 13.
|
Jenkins, G. M.,
Richards, A.,
Wahl, T.,
Mao, C.,
Obeid, L.,
and Hannun, Y.
(1997)
J. Biol. Chem.
272,
32566-32572
|
| 14.
|
Lucci, A.,
Han, T. Y.,
Liu, Y. Y.,
Giuliano, A. E.,
and Cabot, M. C.
(1999)
Int. J. Oncol.
15,
541-546
|
| 15.
|
Koch, J.,
Gartner, S.,
Li, C. M.,
Quintern, L. E.,
Bernardo, K.,
Levran, O.,
Schnabel, D.,
Desnick, R. J.,
Schuchman, E. H.,
and Sandhoff, K.
(1996)
J. Biol. Chem.
271,
33110-33115
|
| 16.
|
Tani, M.,
Okino, N.,
Mori, K.,
Tanigawa, T.,
Izu, H.,
and Ito, M.
(2000)
J. Biol. Chem.
275,
11229-11234
|
| 17.
|
El Bawab, S.,
Roddy, P.,
Qian, T.,
Bielawska, A.,
Lemasters, J. J.,
and Hannun, Y. A.
(2000)
J. Biol. Chem.
275,
21508-21513
|
| 18.
|
Nikolova-Karakashian, M.,
Morgan, E. T.,
Alexander, C.,
Liotta, D. C.,
and Merrill, A. H., Jr.
(1997)
J. Biol. Chem.
272,
18718-18724
|
| 19.
|
Mao, C.,
Xu, R.,
Bielawska, A.,
and Obeid, L. M.
(2000)
J. Biol. Chem.
275,
6876-6884
|
| 20.
|
Okino, N.,
Ichinose, S.,
Omori, A.,
Imayama, S.,
Nakamura, T.,
and Ito, M.
(1999)
J. Biol. Chem.
274,
36616-36622
|
| 21.
|
Tani, M.,
Okino, N.,
Mitsutake, S.,
Tanigawa, T.,
Izu, H.,
and Ito, M.
(2000)
J. Biol. Chem.
275,
3462-3468
|
| 22.
|
El Bawab, S.,
Bielawska, A.,
and Hannun, Y. A.
(1999)
J. Biol. Chem.
274,
27948-27955
|
| 23.
|
Mao, C.,
Wadleigh, M.,
Jenkins, G. M.,
Hannun, Y. A.,
and Obeid, L. M.
(1997)
J. Biol. Chem.
272,
28690-28694
|
| 24.
|
Bielawska, A.,
and Hannun, Y. A.
(1999)
Methods Enzymol.
311,
499-518
|
| 25.
|
Bielawska, A.,
Szulc, Z.,
and Hannun, Y. A.
(1999)
Methods Enzymol.
311,
518-547
|
| 26.
|
Mao, C.,
Saba, J. D.,
and Obeid, L. M.
(1999)
Biochem. J.
342,
667-675
|
| 27.
|
Wells, G. B.,
Dickson, R. C.,
and Lester, R. L.
(1998)
J. Biol. Chem.
273,
7235-7243
|
| 28.
|
Ohnishi, Y.,
Okino, N.,
Ito, M.,
and Imayama, S.
(1999)
Clin. Diagn. Lab. Immunol.
6,
101-104
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. J. Mousley, K. Tyeryar, K. E. Ile, G. Schaaf, R. L. Brost, C. Boone, X. Guan, M. R. Wenk, and V. A. Bankaitis
Trans-Golgi Network and Endosome Dynamics Connect Ceramide Homeostasis with Regulation of the Unfolded Protein Response and TOR Signaling in Yeast
Mol. Biol. Cell,
November 1, 2008;
19(11):
4785 - 4803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Dickson
Thematic Review Series: Sphingolipids. New insights into sphingolipid metabolism and function in budding yeast
J. Lipid Res.,
May 1, 2008;
49(5):
909 - 921.
[Abstract]
[Full Text]
[PDF]
![]() | |